Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Xiaofan Guo

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7220-5094; OpenAlex author ID A5074803827. Sources: OpenAlex.

Their work

Papers
6 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
26
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 2 papers · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 6

  1. CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer. Co-author DOI 10.1038/s41467-026-75132-3↗
  2. Clinical outcomes of second-line chemotherapy in patients with advanced pancreatic adenocarcinoma: a real-world study. First author DOI 10.20892/j.issn.2095-3941.2024.0036↗
  3. Survival outcomes of neoadjuvant therapy followed by radical resection versus upfront surgery for stage I-III pancreatic ductal adenocarcinoma: a retrospective… Co-author DOI 10.1097/js9.0000000000000425↗
  4. Selective extended dissection for pancreaticoduodenectomy is associated with better survival in pancreatic cancer patients: retrospective cohort study. Co-author DOI 10.1097/js9.0000000000000437↗
  5. Delta HU is a potential marker to predict chemotherapy response for unresectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2021.02.016↗
  6. KIF23 enhances cell proliferation in pancreatic ductal adenocarcinoma and is a potent therapeutic target. Co-author DOI 10.21037/atm-20-1970↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jihui Hao · 5 shared papers, 2021–2026 · strength 0.90
  2. Wenbo Zhu · 2 shared papers, 2023–2024 · strength 0.40
  3. Tianxing Zhou · 2 shared papers, 2023–2026 · strength 0.37
  4. Song Gao · 2 shared papers, 2021–2023 · strength 0.31
  5. Chuntao Gao · 2 shared papers, 2020–2023 · strength 0.30
  6. Yizhang Zhou · 2 shared papers, 2020–2021 · strength 0.26
  7. Xingyun Chen · 1 shared paper, 2024 · strength 0.22
  8. Jing Huang · 1 shared paper, 2024 · strength 0.22
  9. Yuxiao Liu · 1 shared paper, 2024 · strength 0.22
  10. Song Gao · 1 shared paper, 2024 · strength 0.22
  11. Xuan Zhou · 1 shared paper, 2026 · strength 0.21
  12. Min Li · 1 shared paper, 2026 · strength 0.21
  13. Bo Wang · 1 shared paper, 2026 · strength 0.21
  14. Quan Zhou · 1 shared paper, 2026 · strength 0.21
  15. Yu Wang · 1 shared paper, 2026 · strength 0.21
  16. Lei Zheng · 1 shared paper, 2026 · strength 0.21
  17. Mien‐Chie Hung · 1 shared paper, 2026 · strength 0.21
  18. Chongbiao Huang · 1 shared paper, 2023 · strength 0.18
  19. Yucheng Zhou · 1 shared paper, 2023 · strength 0.18
  20. Xiuchao Wang · 1 shared paper, 2023 · strength 0.16
  21. Tiansuo Zhao · 1 shared paper, 2023 · strength 0.16
  22. Yiping Zou · 1 shared paper, 2023 · strength 0.16
  23. Yongjie Xie · 1 shared paper, 2023 · strength 0.16
  24. Shengnan Li · 1 shared paper, 2020 · strength 0.13
  25. Shuai Yuan · 1 shared paper, 2021 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.